Automated vulnerability testing identifies patients with inadequate defibrillation safety margin

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Medical Device Technology

Background:

• Implantable cardioverter-defibrillator (ICD) systems require efficacy testing at implantation, typically via induced ventricular fibrillation (VF).
• Assessing defibrillation safety margins without VF induction is possible using upper limits of vulnerability, but historically required manual T-wave timing.
• Manual T-wave timing is a limitation in current defibrillation safety margin assessments.

Purpose of the Study:

• To evaluate the feasibility of an inductionless system for implant testing of ICDs.
• To assess an automated vulnerability safety margin system that measures T-wave timing.
• To determine if automated testing can reduce the need for VF induction during ICD implantation.

Main Methods:

• A multicenter prospective study enrolled 60 patients undergoing ICD implantation.
• An automated system measured T-wave timing via intracardiac electrogram during ventricular pacing, delivering up to 4 T-wave shocks.
• Lack of VF induction by the automated system was considered adequate; patients then underwent conventional defibrillation testing.

Main Results:

• The automated system tested 54 patients, inducing VF in 10 (19%), with 2 requiring system revision.
• All patients not induced by the automated system were successfully defibrillated at ≤25 J.
• Bayesian statistics indicated a 97% to 100% credible interval for defibrillation success at 25 J in non-induced patients.

Conclusions:

• The automated system effectively identified patients failing conventional safety margin testing while minimizing VF induction.
• This automated approach shows feasibility for reducing the need for VF induction in ICD implant testing.
• Further studies with larger sample sizes are warranted to confirm these findings.